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Copper is an essential trace element necessary for normal growth and development. During pregnancy, copper is transported from
the maternal circulation to the fetus by mechanisms which have not been clearly elucidated. Two copper transporting ATPases,
Menkes (ATP7A; MNK) and Wilson (ATP7B; WND) are known to be expressed in the placenta and are thought to have a role
in copper transport to the fetus. In this study, the expression and localization of the MNK and WND proteins in the human
placenta were investigated in detail using immunoperoxidase and double-label immunohistochemistry. MNK and WND are
diﬀerentially localized within the placenta. MNK is present in the syncytiotrophoblast, the cytotrophoblast and the fetal vascular
endothelial cells whereas WND is only in the syncytiotrophoblast. Placental levels of both proteins, measured by Western blot
analysis, did not change across pregnancy. These data oﬀer some insights into possible roles for MNK and WND within the
placenta.
 2003 Elsevier Ltd. All rights reserved.Placenta (2004), 25, 512–517
INTRODUCTION
Copper is an essential trace element, necessary for the survival
of all living organisms. It is central to the function of many
enzymes forming an integral part of the active site. Copper
is able to cycle between a stable oxidized state, Cu(II) and
an unstable reduced state, Cu(I), a property utilized by
cuproenzymes involved in redox reactions [1].
The importance of copper for humans is illustrated in two
inherited disorders of copper metabolism, Menkes and Wilson
disease. Menkes disease is a X-linked recessive disorder,
caused by mutations in the gene MNK; ATP7A [2–4]. This
leads to reduced absorption of copper from intestinal cells
and defective distribution around the body [5], resulting in
deficiencies in the activity of important copper-dependent
enzymes, such as cytochrome c oxidase and lysyl oxidase. Key
features of Menkes disease include abnormal hair structure,
progressive cerebral degeneration, vascular aneurysms and
thrombosis body [5]. Wilson disease is an autosomal recessive
disorder caused by a mutation in the Wilson gene, WND;
ATP7B [6–8] resulting in toxic copper accumulation in the
liver, and brain [5]. Patients with Wilson disease show a range
of clinical conditions including chronic hepatitis, cirrhosis and
neurological disturbances including movement disorders,
due to the toxic accumulation of copper in the liver and
brain [9].
The expression patterns of MNK and WND mRNAs are
markedly diﬀerent. While MNK mRNA is widely expressed in
most adult tissues and the placenta, with little expression in the
liver [4], WND is expressed predominantly in the liver [6]. An
exception to this is the breast, which expresses both MNK and
WND at similar levels [10]. Although mRNA transcripts of
both MNK and WND have been detected in the human
placenta [4,6], nothing is known about the distribution of the
proteins in this tissue. Furthermore, the specific roles of these
copper transporting ATPases in the placenta are unknown. To
understand the function of MNK and WND in the placenta,
we investigated their expression and localization in placentae
across pregnancy.
MATERIALS AND METHODS
Tissue samples
Placentae were obtained from healthy women undergoing
termination of pregnancy for psychosocial reasons in the first
trimester (7–9 weeks of gestation, n=5) and second trimester of
pregnancy (15–18 weeks of gestation, n=5). Placentae were also
collected from five healthy women with a normal, uncompli-
cated, singleton pregnancy, delivered by Caesarean section at
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term (37–40 weeks). Tissue was snap frozen in liquid nitrogen
and stored at 80(C for protein expression studies. Samples
were also fixed for 12–16 h in 10 per cent neutral buﬀered
formalin for paraﬃn embedding and frozen in tissue freezing
medium OCT (Optimum Cutting Temperature) for immuno-
histochemistry. The collection of tissue for research purposes
was approved by the Southern Health Human Research and
Ethics Committee and written informed consent was obtained
from each patient.
Total protein content
Frozen tissue was homogenized in 1 per cent Sodium Dodecyl
Sulphate (SDS) in 10 m Tris–HCl, pH 7.5 then sonicated for
complete cell disruption. The homogenate was centrifuged at
13 000 rpm at 4(C for 10 min, supernatant collected and
mixed with protease inhibitor (Complete Mini Protease Inhibi-
tor Cocktail Tablets, Roche Diagnostics, Castle Hill, NSW,
Australia). The total protein content was measured using the
DC Protein Assay Kit (Bio-Rad Laboratories, California,
USA) calibrated against bovine serum albumin (BSA)
standards.
Western blot analyses
Between 30–60 µg of total protein was separated by SDS/
PAGE and transferred to nitrocellulose membranes (Pall
Gelman, Ann Arbor, Michigan, USA). Membranes were
blocked in 1 per cent (w/v) casein in Tris Buﬀered Saline
(TBS) overnight at 4(C. Diluted primary antibodies were
applied and incubated for 2 h at room temperature. Polyclonal
MNK and WND antibodies (ATP7A [10] and ATP7B; M.
Cater, Manuscript in Preparation) were diluted 1/10 000 and
monoclonal antibody against the trophoblast marker cyto-
keratin 18 (clone CY-90, Sigma, St Louis, MO, USA) diluted
1/500. Membranes were rinsed and exposed to 1/2000
dilution of HRP-conjugated secondary antibody (Silenus,
Melbourne, Australia) for 1 h at room temperature. After
washing oﬀ excess secondary antibody, membranes were rinsed
twice in TBS with 0.1 per cent tween 20. Proteins were
detected by enhanced chemiluminescence (POD Chemilumi-
nescence Blotting Substrate, Roche Diagnostics). To monitor
protein loading, membranes were stripped in Re-Blot solution
(Chemicon International, Temecula, CA, USA) and re-probed
with monoclonal -actin primary antibody (Sigma) diluted
1/3000. A solution consisting of 1 per cent casein in TBS was
used for washing as well as the antibody diluent. Lysates
prepared from the breast cancer cell line PMC42 were used as
a positive control for MNK and WND proteins. Densitometry
to quantify results was performed using a Bio-Rad Gel Doc
(GS-710 Calibrated Imaging Densitometer) and Bio-Rad
Quantity 1.0 computer software.
Immunohistochemistry
Sections 5 µ in thickness were cut from paraﬃn embedded
and frozen tissue. Primary antibodies were diluted in 1 per
cent (w/v) BSA in phosphate buﬀered saline (PBS) and
washes between steps carried out with PBS. Paraﬃn sections
were dewaxed in xylene and rehydrated. Antigen retrieval was
performed by boiling in citrate buﬀer, pH 6 (35 min), using
a microwave. Slides were cooled in citrate buﬀer for 20 min
and endogenous peroxidase activity quenched by applying
3 per cent H2O2 in methanol for 15 min. Non-specific binding
was blocked by incubating with 3 per cent BSA in PBS for
10 min. Primary antibodies (MNK diluted 1/100 and WND
1/10000) were applied and left overnight at 4(C. Sections
were exposed to biotinylated secondary antibodies (LSAB Kit,
DAKO, Carpintaria, CA, USA) and staining visualized with
the chromogen 3,3#-diaminobenzidine tetrahydrochloride
(Sigma).
Co-localization studies were carried out on cryosections by
single and double label indirect immunofluorescence. Sections
were fixed in 4 per cent (w/v) paraformaldehyde in PBS for
10 min and permeabilized with 5 per cent (v/v) Triton X-100
(Sigma) in PBS for 5 min. Sections were blocked in 3 per cent
BSA in PBS for 1 h at room temperature and incubated
overnight at 4(C with antibodies against MNK (diluted 1/50),
WND (diluted 1/10 000) or the endothelial cell marker CD34
(monoclonal, Serotec, Raleigh, NC, USA, diluted 1/20).
Fluorescent tagged secondary antibodies (Alexa 488 or 568
Molecular Probes, Eugene, OR, USA) diluted 1/1000 were
applied for 2 h. After washing oﬀ excess secondary antibodies,
slides were dried and mounted in Antifade Reagent (Bio-Rad).
Negative control sections for immunohistochemistry consisted
of primary antibodies substituted with 1/1000 pre-immune
serum in PBS.
Statistics
Data are presented as meanss.d. Statistical analyses were
carried out using an unpaired t-test with unequal variance and
ANOVA analysis.
RESULTS
Western blot analysis
Placental samples from five unrelated individuals were each
analysed three times to detect MNK and WND using Western
blot analysis. Bands of size 178 kDa bands, consistent with that
of MNK [11] were detected in all placental tissues (Figure 1A).
Levels (means.d.) of the MNK protein relative to -actin, a
housekeeping protein expressed in all cells of the placenta,
changed significantly across pregnancy (19.42, 7.91 and
15.61 optical density units/mm2) in the 1st, 2nd and 3rd
trimesters, respectively (P<0.001; unpaired t-test), as deter-
mined by densitometric analysis of the blots. Western blot
analysis of cytokeratin 18 was carried out to determine the
relative amount of protein derived from the trophoblast across
gestation (Figure 1C), as this marker is specific for the
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trophoblast and not present in other cell types in the placenta
including vascular endothelial cells and fibroblasts. Although
the ratio of MNK to cytokeratin 18 did not alter significantly
across the three trimesters (2.2, 2.3, 2.0; P=0.1, ANOVA, as
measured by densitometry), it cannot be conclusively con-
cluded that MNK expression in the trophoblast remains
constant, as MNK was also detected in the vascular endothelial
cells. A 165 kDa protein band, consistent with the expected
size of WND [12] was also detected in placenta from all
trimesters (Figure 1B). The densitometry values for the WND
protein were 38.13, 13.92 and 19.42 optical density
units/mm2 for 1st, 2nd, and 3rd trimesters respectively
(P<0.001; t-test). The densitometry ratios of WND relative to
cytokeratin 18 (Figure 1C) did not alter significantly across the
three trimesters (1.2, 1.3, 1.6; P=0.8, ANOVA) respectively,
indicating that the amount of WND expressed in the tropho-
blast did not vary across gestation.
Immunolocalization of MNK and WND
Figure 2 shows the localization of MNK and WND in
placenta. Across pregnancy, MNK was mainly immuno-
localized to the syncytiotrophoblast, the cytotrophoblast and
fetal vascular endothelial cells with some stromal staining
(Figure 2A–C). In all trimesters, WND was immunolocalized
only to the syncytiotrophoblast with no immunostaining
apparent in the cytotrophoblast, endothelial cells or stroma
(Figure 2D–F). WND appeared to have a more dispersed
intracellular location than MNK.
Figure 3 shows double-label indirect immunofluorescence
for MNK (Figure 3A—red) and WND (Figure 3B—green)
and confirmed co-localization (Figure 3C—orange) in the
syncytiotrophoblast in first trimester villus trophoblast, with
only MNK in the stroma. In third trimester placenta (Figure
3D–F), the pattern of staining was similar to first trimester,
with both MNK and WND in the syncytiotrophoblast and
only MNK in the stroma. However, there was less overlap in
the distribution of the two proteins seen in the third semester
relative to the first trimester. MNK is also localized in the
vascular endothelial cells as shown in Figure 3, where there is
staining of MNK (Figure 3H—green) and CD34 (Figure
3G—red) and co-localization (Figure 3I—orange) in the
endothelial cells in the term villus.
DISCUSSION
That MNK is important for normal development is evidenced
in babies with Menkes disease. Due to copper deficiency,
Menkes babies are lethargic, have sparse hair and develop
hypothermia and convulsions, leading to death within the first
year of life [13,14]. The symptoms of Wilson disease, including
chronic liver disease and neurological manifestations, com-
monly develop between the ages of 5 and 33 years of age [9].
The role of WND in early development is not clear but as
copper accumulates in the placenta during gestation in both
Menkes and Wilson disease [15,16] a role for both copper
ATPases in the transfer of copper across the placenta is likely.
This is supported by mouse models of Menkes and Wilson
diseases that suggest, in the mouse, that these ATPases
participate in placental copper transport. Mouse fetuses, which
have mutations in the MNK orthologue, Mnk have elevated
levels of placental copper [17] and defective placental transfer
of copper in utero [18]. Mice in which the Wnd gene was
knocked out have a four-fold increase in placenta copper levels
compared with control mice [19]. Pups of dams of the mutant
toxic milk mouse which have a missense mutation in Wnd [20]
are born copper deficient [21] possibly due to defective
placental transport.
Figure 1. Western blot analysis of MNK protein (A) and WND protein (B)
in placentae from 1st trimester (Lane 2), 2nd trimester (Lane 3) and 3rd
trimester (Lane 4). Similar sized bands were also found in PMC42 breast cell
extracts, which were used as a positive control (Lane 1). The membranes were
re-probed with an antibody to the housekeeping protein -actin, indicating
equal loading of sample protein from each tissue extract. Western blot analysis
of cytokeratin 18 protein (C) in placentae from 1st trimester (Lane 1), 2nd
trimester (Lane 2) and 3rd trimester (Lane 3). The membranes were re-probed
with an antibody to the housekeeping protein -actin, indicating equal loading
of sample protein from each tissue extract.
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Our study is the first to localize and quantify the MNK and
WND proteins in the human placenta at various stages of
pregnancy. The localization of the MNK protein to the
syncytiotrophoblast and cytotrophoblast and to fetal vascular
endothelial cells is consistent with MNK being a copper
transporter across these cells and transport into the fetal
circulation. The previous observation that cultured cells from
patients with Menkes disease had reduced copper eﬄux [22]
suggests that in the placenta MNK most likely facilitates
copper transport by mediating copper eﬄux into the fetal
circulation. It has been proposed that copper follows a trans-
port pathway down a concentration gradient in the maternal to
fetal direction [23] and studies using microvillar vesicles from
human placenta showed that copper uptake occurred by a
carrier-mediated processes [24]. The localization of MNK
within the trophoblast cells suggest that a key transport role
may be to transfer copper from the basolateral surface of the
syncitiotrophoblast. This location and function is consistent
with its function and localization in the gut where it is involved
in copper eﬄux from basal surface of the mouse enterocyte
(Mercer, unpublished observations). MNK was also found in
the vascular endothelial cells, suggesting that it might be
involved in transport of copper into the fetal circulation.
Future studies using electron microscopy would provide more
accurate information about the intracellular site of localization
of MNK and WND. It is also possible that, within the
placenta, MNK may transport copper to cupro-enzymes, such
as lysyl oxidase, required for collagen synthesis [25]. Evidence
that the MNK ATPase supplies copper to secreted cupro-
enzymes is seen in Menkes patients whose cultured fibroblasts
have reduced lysyl oxidase activity [26].
In contrast to MNK, WND appeared to localize only within
the cells of the syncytiotrophoblast in all three trimesters.
WND was not detected in the cytotrophoblast cells. The
intracellular distribution of WND appeared to be diﬀerent
from MNK, suggesting that these proteins may have diﬀerent
roles. In the liver, WND is required for secretion of copper
into bile [9] and within hepatocytes it is found in the secretory
pathway, where it has a vesicular localization [27]. The
distribution of WND within the trophoblast was diﬀerent from
MNK. As WND is located toward the apical surface of the
hepatocyte [27,35,36] and required for secretion of copper
from hepatocyte, we propose that WND may located to eﬄux
copper from the apical surface of the placenta toward the
mother, as a mechanism to prevent excess copper from
reaching the fetus. The concentration of copper in the ma-
ternal sera has been reported to be five times that in the
umbilical cord [37], which would create a gradient promoting
movement of copper into the fetus. WND is also required for
incorporation of copper into ceruloplasmin, a multi-copper
oxidase which is important for iron metabolism [28]. Since
ceruloplasmin is expressed in the placenta [29], it is also
possible that WND has a function in copper delivery to
ceruloplasmin and plays a role in delivery of iron to the fetus.
Such a function has been proposed, but not demonstrated, in
studies on BeWo choriocarcinoma cells, which express a
ferroxidase with similar immunoreactivity to ceruloplasmin
[30].
Figure 2. Immunoperoxidase labelling of MNK in placentae from 1st trimester (A), 2nd trimester (B) and 3rd trimester (C). Immunoperoxidase labelling of
WND in placentae from 1st trimester (D), 2nd trimester (E) and 3rd trimester (F). No label was seen in a control section (insert-G), incubated with 1/1000
pre-immune serum, to indicate the specificity of this labelling. Bar=16.5 µm.
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Evidence for the function of MNK in copper eﬄux has
been shown in cultured trophoblast cells. In BeWo cells, the
absence of expression of MNK was accompanied by negligible
release of radiolabelled copper from cells [31] and copper
release from polarized cells was accompanied by expression of
the MNK gene [32]. In another study using BeWo cells, the
WND gene was also found to be expressed and it was proposed
that WND was involved in entry of copper into the Golgi from
the maternal surface while MNK participated in movement of
copper to the fetal surface [33].
The expression of cytokeratin 18, used as a measure of the
relative amount of trophoblast tissue across pregnancy, was
decreased in second semester tissue relative to first and third
trimester tissue. The explanation for this is not clear. Although
the total levels of MNK and WND varied across three
trimesters, the levels of these ATPases relative to cytokeratin
18 did not change across gestation. As WND was detected only
in the trophoblast and not in other cells, this result may
indicate that the expression level of the WND ATPase does
not change greatly throughout gestation. Since MNK was
expressed in endothelial cells as well as in the trophoblast, the
extent to which its expression changes throughout gestation in
diﬀerent cell types cannot be determined in this study. It
might be expected that the demand for copper would be
greatest in the first trimester when the growth rate of the
placenta is highest and there is a 400-fold increase in the levels
of lysyl oxidase (a copper dependent enzyme) mRNA in the
placenta relative to the second and third trimesters [34].
However, an increase in copper transport or activity of MNK
or WND does not necessarily require increased expression of
MNK or WND. In human breast tissue there was no increase
in the MNK or WND protein levels in lactating tissue
compared with non-lactating tissue, despite the secretion of
copper into milk during lactation [11,12].
Figure 3. Double label indirect immunofluorescence of MNK (red) and WND (green) in placentae from 1st trimester (A, B, C) and 3rd trimester (D, E, F).
Double label indirect immunofluorescence of MNK (green) and endothelial cell marker CD34 (red) (G, H, I) in placentae from 3rd trimester. Bar=17 µm.
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In summary, our data show that both MNK and WND
proteins are present in the human placenta across pregnancy.
As MNK is expressed by more than one cell type, it is not clear
how the levels of expression alter in the diﬀerent cells across
the three trimesters. These results suggest, but do not prove,
that marked changes in the overall expression of both proteins
in the whole placenta do not occur across the pregnancy.
Nevertheless, further investigation using more accurate tech-
niques including measurements of mRNA levels in diﬀerent
cell types in which we have shown that MNK and/or WND
are expressed, are needed to elucidate this question. The
diﬀerent patterns of localization of MNK and WND suggest
they may have diﬀerent functions within the placenta. Further
studies will clarify the roles of MNK and WND in export of
copper from placental cells, delivery of copper to enzymes and
supply of copper to ceruloplasmin.
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